Antigen loading of dendritic cells with apoptotic tumor cell-preparations is superior to that using necrotic cells or tumor lysates.
Aug 2007 - Anticancer Res.; 27(4B):0250-7005 [PMID:17695495]
[Inzkirweli N] [Gückel B] [Sohn C] [Wallwiener D] [Bastert G] [Lindner M]

Tumor-cell number and viability as quality and efficacy parameters of autologous virus-modified cancer vaccines in patients with breast or ovarian cancer.
Jul 1997 - J. Clin. Oncol.; 15(4):0732-183X [PMID:9193327]
[Ahlert T] [Sauerbrei W] [Bastert G] [Ruhland S] [Bartik B] [Simiantonaki N] [Schumacher J] [Häcker B] [Schumacher M] [Schirrmacher V]